Relationship between clinical and patient-reported outcomes in a phase 3 trial of tofacitinib or MTX in MTX-naïve patients with rheumatoid arthritis

類似資料

• Efficacy of tofacitinib monotherapy in methotrexate-naive patients with early or established rheumatoid arthritis
  著者:: Fleischmann, Roy M, 等
  出版事項: (2016)
• Tofacitinib versus methotrexate in rheumatoid arthritis: patient-reported outcomes from the randomised phase III ORAL Start trial
  著者:: Strand, Vibeke, 等
  出版事項: (2016)
• Evaluation of disease activity in patients with rheumatoid arthritis treated with tofacitinib by RAPID3: post hoc analyses from two phase 3 trials
  著者:: Strand, Vibeke, 等
  出版事項: (2018)
• Patient-reported outcomes for tofacitinib with and without methotrexate, or adalimumab with methotrexate, in rheumatoid arthritis: a phase IIIB/IV trial
  著者:: Strand, Vibeke, 等
  出版事項: (2019)
• Tofacitinib or adalimumab versus placebo: patient-reported outcomes from a phase 3 study of active rheumatoid arthritis
  著者:: Strand, Vibeke, 等
  出版事項: (2016)